Home / Products / Cancer (Tumor) Cell Lines / EFM-19
EFM-19
Datasheet Protocol

EFM-19

Cat. No. ARC0187
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Breast

Growth Properties:

Adherent

In stock
$1,400.00 / Vial
Ask a Question

Short Description 🔒

EFM-19 is a cancer cell line of breast ductal carcinoma, isolated from metastatic; pleural effusion.

Recommended Products

CALCOCO2 Knockout HEK293T Polyclonal Cells CALCOCO2 Knockout HEK293T Polyclonal Cells Cat. No. ARG25900 NFIX Knockout HT29 Polyclonal Cells NFIX Knockout HT29 Polyclonal Cells Cat. No. ARG15063 ARHGEF16 Knockout MES-OV Polyclonal Cells ARHGEF16 Knockout MES-OV Polyclonal Cells Cat. No. ARG24216 CAMKK1 Knockout NCI-H1299 Polyclonal Cells CAMKK1 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG42042 DAPK1 Knockout 786-O Polyclonal Cells DAPK1 Knockout 786-O Polyclonal Cells Cat. No. ARG4723 LGMN Knockout HEK293T Polyclonal Cells LGMN Knockout HEK293T Polyclonal Cells Cat. No. ARG4357
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Breast
Disease:
Ductal carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
50 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CAMSAP2 Knockout HT29 Polyclonal Cells

CAMSAP2 Knockout HT29 Polyclonal Cells

Cat. No. ARG33225
 AKR1C2 Knockout Hela Cell Line

AKR1C2 Knockout Hela Cell Line

Cat. No. ARG43714
 KDELR1 Knockout A2780 Polyclonal Cells

KDELR1 Knockout A2780 Polyclonal Cells

Cat. No. ARG29290
 DMTN Knockout AGS Polyclonal Cells

DMTN Knockout AGS Polyclonal Cells

Cat. No. ARG38992
 DOCK4 Knockout HAP1 Polyclonal Cells

DOCK4 Knockout HAP1 Polyclonal Cells

Cat. No. ARG39584
 L-WRN

L-WRN

Cat. No. ARI0073